TFFP (TFF Pharmaceuticals) חוב לטווח קצר להון

TFF Pharmaceuticals (TFFP) business relies on the success of licensing inhalation methods and the stability of powder form production. This chart reflects the current market value on GURU.Markets at 0.02, which correlates with a transparent process of patent sales and the firm's liquidation due to a funding deficit. The company is currently stagnating: operational activities have ceased, and drug freezing developments are completely frozen.

This ratio determines the issuer's financial stability through the relationship between short-term liabilities and equity, allowing the investor to assess liquidity risk and the degree of debt load. By analyzing the change in the ratio of short-term borrowed capital to equity, one can confirm the low capital expenditure requirements of TFF Pharmaceuticals (TFFP), as the use of contract manufacturing organizations (CMO) minimizes the need for costly plant ownership.